Genetic Technologies (Australia) Analysis
| GTG Stock | 0.04 0.00 0.00% |
Genetic Technologies is overvalued with Real Value of 0.0336 and Hype Value of 0.04. The main objective of Genetic Technologies stock analysis is to determine its intrinsic value, which is an estimate of what Genetic Technologies is worth, separate from its market price. There are two main types of Genetic Technologies' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Genetic Technologies' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Genetic Technologies' stock to identify patterns and trends that may indicate its future price movements.
The Genetic Technologies stock is traded in Australia on Australian Securities Exchange, with the market opening at 09:50:00 and closing at 16:12:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Australia. Genetic Technologies is usually not traded on King 's Birthday, Christmas Day, Boxing Day, New Year 's Day, Australia Day, Australia Day ( substitute day ), Good Friday, Easter Monday, ANZAC Day. Genetic Stock trading window is adjusted to Australia/Sydney timezone.
Genetic |
Genetic Stock Analysis Notes
The book value of the company was currently reported as 0.01. The company had not issued any dividends in recent years. Genetic Technologies had 1:100 split on the 14th of December 2023. To learn more about Genetic Technologies call the company at 61 3 8412 7000 or check out https://genetype.com.Genetic Technologies Investment Alerts
| Genetic Technologies has some characteristics of a very speculative penny stock | |
| Genetic Technologies had very high historical volatility over the last 90 days | |
| Genetic Technologies has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 7.66 M. Net Loss for the year was (12.02 M) with profit before overhead, payroll, taxes, and interest of 6.01 M. | |
| Genetic Technologies generates negative cash flow from operations | |
| Latest headline from news.google.com: Genetic Technologies Enters Voluntary Administration - TipRanks |
Genetic Technologies Thematic Classifications
In addition to having Genetic Technologies stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ITInformation technology and IT services |
Genetic Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genetic Technologies's market, we take the total number of its shares issued and multiply it by Genetic Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Genetic Profitablity
Genetic Technologies' profitability indicators refer to fundamental financial ratios that showcase Genetic Technologies' ability to generate income relative to its revenue or operating costs. If, let's say, Genetic Technologies is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Genetic Technologies' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Genetic Technologies' profitability requires more research than a typical breakdown of Genetic Technologies' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.24) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.13) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.13. Management Efficiency
Genetic Technologies has return on total asset (ROA) of (0.6293) % which means that it has lost $0.6293 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.8498) %, meaning that it generated substantial loss on money invested by shareholders. Genetic Technologies' management efficiency ratios could be used to measure how well Genetic Technologies manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Genetic Technologies' Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 1.2 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 5.9 M in 2024.Leadership effectiveness at Genetic Technologies is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (1.13) | Profit Margin (1.24) | Beta 0.48 | Return On Assets (0.63) | Return On Equity (1.85) |
Technical Drivers
As of the 28th of November, Genetic Technologies retains the Downside Deviation of 6.6, market risk adjusted performance of (0.41), and Risk Adjusted Performance of 0.0146. Genetic Technologies technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Genetic Technologies Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Genetic Technologies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Genetic Technologies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Genetic Technologies Outstanding Bonds
Genetic Technologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genetic Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genetic bonds can be classified according to their maturity, which is the date when Genetic Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Genetic Technologies Predictive Daily Indicators
Genetic Technologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Genetic Technologies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Genetic Technologies Forecast Models
Genetic Technologies' time-series forecasting models are one of many Genetic Technologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genetic Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Genetic Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Genetic Technologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Genetic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Genetic Technologies. By using and applying Genetic Stock analysis, traders can create a robust methodology for identifying Genetic entry and exit points for their positions.
Genetic Technologies is entity of Australia. It is traded as Stock on AU exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Genetic Technologies to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Additional Tools for Genetic Stock Analysis
When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.